Compliance Under Transformation: Life Sciences And AI At The Crossroads

Regulatory expectations are shifting quickly as FDA modernization efforts, evolving EU frameworks, and emerging AI-driven processes move toward greater alignment. Explore where those changes stand today and what they mean for teams responsible for quality, regulatory strategy, and digital innovation. Panelists break down how medical‑device and pharmaceutical organizations can adapt their quality systems while keeping pace with new technologies, especially AI tools increasingly embedded in development, manufacturing, and compliance workflows.

Gain practical guidance on harmonizing global standards, reducing the risk of audit surprises, and building systems resilient enough to accommodate future reforms. For anyone navigating the intersection of regulation and innovation, this is a chance to understand what’s coming next and how to prepare for it.